Perigon Wealth Management LLC Purchases 304 Shares of Agilent Technologies, Inc. (NYSE:A)

Perigon Wealth Management LLC grew its stake in Agilent Technologies, Inc. (NYSE:A) by 11.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,920 shares of the medical research company’s stock after purchasing an additional 304 shares during the period. Perigon Wealth Management LLC’s holdings in Agilent Technologies were worth $406,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Kepos Capital LP grew its holdings in shares of Agilent Technologies by 3.5% in the 3rd quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock valued at $310,000 after acquiring an additional 93 shares in the last quarter. Ancora Advisors LLC grew its holdings in shares of Agilent Technologies by 41.1% in the 1st quarter. Ancora Advisors LLC now owns 326 shares of the medical research company’s stock valued at $45,000 after acquiring an additional 95 shares in the last quarter. Rosenberg Matthew Hamilton grew its holdings in shares of Agilent Technologies by 51.1% in the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock valued at $39,000 after acquiring an additional 96 shares in the last quarter. Ronald Blue Trust Inc. grew its holdings in shares of Agilent Technologies by 8.1% in the 3rd quarter. Ronald Blue Trust Inc. now owns 1,336 shares of the medical research company’s stock valued at $161,000 after acquiring an additional 100 shares in the last quarter. Finally, Invesco LLC grew its holdings in shares of Agilent Technologies by 0.7% in the 3rd quarter. Invesco LLC now owns 15,471 shares of the medical research company’s stock valued at $1,730,000 after acquiring an additional 101 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $140.22 on Tuesday. The company’s 50 day simple moving average is $141.17 and its 200 day simple moving average is $129.27. The stock has a market capitalization of $41.09 billion, a price-to-earnings ratio of 33.39, a price-to-earnings-growth ratio of 4.26 and a beta of 1.11. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $151.58. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.68 and a quick ratio of 2.04.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.07. The business had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The business’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 earnings per share. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.51 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd will be given a dividend of $0.236 per share. The ex-dividend date of this dividend is Monday, April 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.38%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 19th. Oppenheimer raised their target price on shares of Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, March 26th. UBS Group raised their target price on shares of Agilent Technologies from $130.00 to $155.00 and gave the company a “neutral” rating in a research note on Wednesday, February 28th. JPMorgan Chase & Co. raised their target price on shares of Agilent Technologies from $140.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, December 20th. Finally, Citigroup raised their target price on shares of Agilent Technologies from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $141.29.

Insider Transactions at Agilent Technologies

In related news, VP Rodney Gonsalves sold 4,828 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $149.00, for a total value of $719,372.00. Following the sale, the vice president now owns 21,329 shares in the company, valued at approximately $3,178,021. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, VP Rodney Gonsalves sold 4,828 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $149.00, for a total value of $719,372.00. Following the sale, the vice president now owns 21,329 shares in the company, valued at approximately $3,178,021. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Philip Binns sold 2,827 shares of the company’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $147.54, for a total transaction of $417,095.58. Following the completion of the sale, the senior vice president now owns 9,997 shares in the company, valued at approximately $1,474,957.38. The disclosure for this sale can be found here. Insiders have sold 61,610 shares of company stock valued at $9,220,333 in the last 90 days.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.